Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Pipeline portfolio

PART 06: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 07: Market segmentation by disease type

Rheumatoid arthritis

Osteoarthritis

Osteoporosis

Psoriatic arthritis

Ankylosing spondylitis

Fibromyalgia

PART 08: Global rheumatoid arthritis drugs market

Market overview

PART 09: Global osteoarthritis drugs market

Market overview

PART 10: Global osteoporosis drugs market

Market overview

PART 11: Global ankylosing spondylitis drugs market

Market overview

PART 12: Global psoriatic arthritis drugs market

Market overview

PART 13: Global fibromyalgia drugs market

Market overview

PART 14: Market segmentation by type of molecule

Biologics

Small molecules

PART 15: Market segmentation by route of

administration

Parenteral

Topical

Oral

PART 16: Geographical segmentation

Global musculoskeletal disorder therapeutics market by

geography 2015-2020

Musculoskeletal disorders therapeutics market in

Americas

Musculoskeletal disorders therapeutics market in

EMEA

Musculoskeletal disorders therapeutics market in

APAC

PART 17: Market drivers

High growth potential of mAbs

Unmet needs of therapeutics

Tentative approval of advanced drugs

Technological advancements in medical imaging

Combination therapies

PART 18: Impact of drivers

PART 19: Market challenges

Non-adherence to treatment regimen

Growing preference toward surgeries

Multiple patent expiries

PART 20: Impact of drivers and challenges

PART 21: Market trends

Focus on regenerative medicines

Ongoing active clinical trials for biosimilars

Growing focus toward abuse-resistant novel drugs

PART 22: Vendor landscape

Competitive scenario

PART 23: Key vendor analysis

AbbVie

Johnson & Johnson

Amgen

Pfizer

F. Hoffmann-La Roche

Eli Lilly

Other prominent vendors

PART 24: Appendix

List of abbreviations

PART 25: Explore Technavio